7:30-8am |
Coffee
|
Researcher's Track
|
8-9am |
Antigen Identification (50 min. presentation with 10 min. Q&A)
James Heath, PhD Institute for Systems Biology
|
9-9:15am |
Break
|
9:15-10:15am |
Pre-Clinical Animal Models (50 min. presentation with 10 min. Q&A)
Maryland Franklin, PhD Labcorp
|
10:15-10:20am |
Transition
|
10:20-11:20am |
Autoimmunity and irAEs (50 min. presentation with 10 min. Q&A)
Ryan Sullivan, MD Harvard Medical School and Massachusetts General Hospital
|
11:20-11:25am |
Transition
|
11:25am-12:25pm |
Tumor Cell Analyses (Pathology) (50 min. presentation with 10 min. Q&A)
Tricia Cottrell, MD, PhD Queen's University
|
12:25-1:25pm |
Networking Lunch (includes optional Patient Advocate info tables)
|
1:25-2:25pm |
Applications of Computational Biology/Machine Learning to Immuno-Oncology (50 min. presentation with 10 min. Q&A)
Robert Scharpf, PhD Johns Hopkins University
|
2:25-2:40pm |
Break
|
Clinician's Track
|
8-9am |
Phase I Immunotherapy Clinical Trials (50 min. presentation with 10 min. Q&A)
Chris Takimoto, MD, PhD START Research
|
9-9:15am |
Break
|
9:15-10:15am |
Phase II and Phase III Immunotherapy Clinical Trials (50 min. presentation with 10 min. Q&A)
Elizabeth Garrett-Mayer, PhD American Society of Clinical Oncology
|
10:15-10:20am |
Transition
|
10:20-11:20am |
How to Get a Predictive Biomarker out of every Clinical Trial (50 min. presentation with 10 min. Q&A)
Gregory Lesinksi, PhD, MPH Winship Cancer Institute at Emory University
|
11:20-11:25am |
Transition
|
11:25am-12:25pm |
Regulatory Issues Related to Cancer Immunotherapy (50 min. presentation with 10 min. Q&A)
Bambi Grilley, RPh Baylor College of Medicine
|
12:25-1:25pm |
Networking Lunch (includes optional Patient Advocate info tables)
|
1:25-2:25pm |
Immunotherapy in Special Patient Populations (50 min. presentation with 10 min. Q&A)
Zachary Buchwald, MD, PhD Emory University
|
2:25-2:40pm |
Break
|
Small Group/Hands On Sessions for Everyone
|
2:40-3:40pm |
Deep TCR and BCR Sequencing as a Biomarker for Cancer - Virtual Presentation (50 min. presentation with 10 min. Q&A)
Sacha Gnajtic, PhD Icahn School of Medicine at Mount Sinai
|
Industry-Led Session: New Agents (50 min. presentation with 10 min. Q&A)
Chris Takimoto, MD, PhD START Research
|
TCR T Cell Therapy (50 min. presentation with 10 min. Q&A)
Kristin Anderson, PhD University of Virginia
|
3:40-3:55pm |
Break
|
Small Group/Hands On Sessions for Everyone
|
3:55-4:55pm |
Intratumoral and Local Therapy (50 min. presentation with 10 min. Q&A)
Masataka Suzuki, PhD Baylor College of Medicine
|
GMP: The Science of Manufacturing (50 min. presentation with 10 min. Q&A)
Bruce Levine, PhD Abramson Cancer Center
|